Gastroenterology & Hepatology

Samer Gawrieh, MD
Associate Professor
Doctor of Medicine (MD)
Aleppo University, Aleppo, Syria, 1996
Residency
Internal Medicine, Cook County Hospital, Chicago, IL, 1998-2001
Fellowship
Fellowship, Gastroenterology, Medical College of Wisconsin, Milwaukee, 2001-2004

Clinical Interests & Patient Appointments

PUBLICATIONS (To view complete Curriculum Vitae, click here)

Manuscripts

1. Gawrieh S, Knoedler DM, Saeian K, Wallace JR, Komorowski RA. Effects of interventions on intra- and inter-observer agreement on interpretation of non-alcoholic fatty liver disease histology. In press 2010 Ann Diagn Pathol.
    
2. Gawrieh S, Mersha T, Carless M,  Wallace J, Komorowski R, Kleiner DE, Andris D, Makladi B, Cole R, Charlton M, Curran J, Dyer T, Charlesworth J, Wilke R, Blangero J, Kissebah A, Olivier M. Hepatic Gene Networks in Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease. Obes Surg. 2010 May 16. [Epub ahead of print].
    
3. Ulitsky A, Ananthakrishnan AN, Komorowski R, Wallace J, Surapaneni SN, Franco J, Saeian K, Gawrieh S. A Non-Invasive Clinical Scoring Model Predicts Risk of Non-Alcoholic Steatohepatitis in Morbidly Obese Patients. Obes Surg. 2010 Mar 25. [Epub ahead of print].
    
4. Smith EM, Zhang Y, Baye TM, Gawrieh S, Cole R, Blangero J, Carless MA, Curran JE, Dyer TD, Abraham LJ, Moses EK,  Kissebah AH,  Martin LJ, and  Olivier M. INSIG1 influences obesity-related hypertriglyceridemia in humans . J Lipid Res. 2010 Apr;51(4):701-8.
    
5. Charlton M, Angulo P, Chalasani N, Merriman R, Viker K, Charatcharoenwitthaya P, Sanderson S, Gawrieh S, Krishnan A, Lindor K. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology. 2007 Dec 27;47(2):484-492.
    
6. Gawrieh S, Carroll T, Hogan WJ, Soergel KH, Shaker R. Swallow syncope in association with schatzki ring and hypertensive esophageal peristalsis: report of three cases and review of the literature. Dysphagia. 2005 Fall;20(4):273-7.
    
7. Gawrieh S, Papouchado BG, Burgart  LJ, Kobayashi S, Charlton MR, Gores GJ.  Early Hepatic Stellate Cell Activation Predicts Severe Hepatitis C Recurrence after Liver Transplantation. Liver Transpl. 2005 Oct;11(10):1207-13.
    
8. Gawrieh S, Massey BT, Komorowski RA. scalp metastases as the first manifestation of pancreatic cancer. Dig Dis Sci. 2002 Jul;47(7):1469-71.

Abstracts

1. Gawrieh, S, Hogan, WJ, Caroll, T, and Shaker, R. 2002. Deglutitive syncope associated with esophageal dysphagia. Gastroenterology: 122: A362.  Presented as a poster at DDW, San Francisco, CA – 2002.
    
2. Gawrieh, S, Prajapati, DN, Saeian, K, Varma, RR, Franco, J, Knox, JF, Kern, M, and Binion, DG. 2002. Prevalence and patterns of liver tests abnormalities in patients with inflammatory bowel Disease. Hepatology: 36(4): A334.  Presented as a poster in AASLD Meeting, Boston, MA – 2002.
    
3. Gawrieh, S, Jean, MC, and Massey, BT. 2003. Not just a failure to relax: Timing and magnitude of lower esophageal sphincter after-contractions also contribute to esophageal outflow obstruction in achalasia. Gastroenterology: 124(4): A161.  Presented as a Poster of Distinction for DDW, Orlando, FL – 2003.
    
4. Gawrieh, S, Rosado, B, Lindor, K, and Charlton, MR. 2004. Adipokine levels are predictive of histology in patients with non-alcoholic fatty liver disease. Hepatology: 40(4): A270.  Selected for Oral Presentation for AASLD Presidential Plenary Session, Boston, MA – 2004.
    
5. Gawrieh, S, Papouchado, BG, Kobayashi, S, Charlton, MR, and Gores, GJ. 2004. Mesenchymal hepatic stellate cells activation index predicts progressive hepatitis C virus recurrence after liver transplantation. Hepatology: 40(4): A242.  Selected for Oral Presentation for AASLD Parallel Session, Boston, MA – 2004.
    
6. Gawrieh, S, Eckert, J, Komorowski, R, Wallace, J, Kissebah, A, and Olivier, M. 2006. Genetic Variation of Protein Tyrosine Phosphatase 1 Beta in Non-Alcoholic Fatty Liver Disease. Presented as a poster at Keystone Symposia, Big Sky, MT – 2006.
    
7. Charlton, MR, Angulo Hernandez, P, Charatcharoenwitthaya, P, Burgart, L, Gawrieh S, Lindor, K, Viker, K, and Krishnan, A. 2006. Low Circulating DHEA Levels in Severe Non-alcoholic Fatty Liver Disease – A Potential Metabolic Basis of Disease Progression. Gastroenterology: 130(4): A22. Selected for Oral Presentation for Digestive Disease Week, Los Angeles, CA – 2006.
    
8. Gawrieh, S, Eckert, J, Komorowski, R, Cole, R, Wallace, J, Kissebah, A, and Olivier, M. 2006. A Protein Tyrosine Phosphatase 1 Beta (PTP-1B) Risk Haplotype is Associated with Non- Alcoholic Steatohepatitis in Females. Hepatology: 44(4): A656.
    
9. Katopes, CP, Surapaneni, SN, Komorowski, R, Behmaram, B, Wallace, J, Nuttleman, P, Franco, J, Varma, R, Massoud, O, Saeian, K, Gawrieh, S. 2007. Variability in the histologic interpretation of non-alcoholic fatty liver disease. Gastroenterology: 132(4): A2160.
    
10. Gawrieh S, Marion M, Smith K, Komorowski R, Wallace J, Nuttleman P, Andris D, Kissebah A, Langefeld C, Olivier M. 2007. Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with NAFLD and its histological phenotypes. Am J Gastro, 102,  Suppl 2: 5246. Presented as a poster at The American College of Gastroenterology Annual Scientific Meeting, Philadelphia, PA – 2007.
     
11. Surapaneni S, Katopes C, Wallace J, Nuttleman P, Andris D, Behnaz B, Komorowski R, Franco J, Varma R, Massoud O, Saeian K, Gawrieh S. 2007. Prediction of histology in nonalcoholic fatty liver disease: do medications matter?. Am J Gastro, 102, Suppl 2: 5242. Presented as a poster at The American College of Gastroenterology Annual Scientific Meeting, Philadelphia, PA – 2007.
     
12. Meier K, Komorowski R, Wallace J, Nuttleman P, Andris D, Gawrieh S. 2007. Liver Pathology in Patients With Suspected Nonalcoholic Fatty Liver Disease. Am J Clin Pathol 2007, 128:708.Presented as a poster at The American Society for Clinical Pathology Annual Meeting, New Orleans, LA – 2007.
     
13. Gawrieh S,  Wallace J, Carless M, Komorowski R, Nuttleman P, Andris D, Makladi B,  Kleiner DE,  Curran J,  Dyer TD,  Charlesworth J,  Blangero J, Kissebah A, Olivier O. 2008. Discovery of gene networks involved in non-alcoholic fatty liver disease using genome-wide transcriptional profiling. Hepatology: 48(4): Supp 1, A811. Presented as a poster at AASLD meeting, San Francisco, CA – 2008.
     
14. Kwiatt J, Desai M, Gawrieh S, Saeian S. Use of a patient registry database to improve hepatocellular carcinoma screening, vaccination rates, and esophageal varices screening in patients with cirrhosis. Gastroenterology 2009; 136 (Suppl 1):M1003.
     
15. Patel A, Gawrieh S, Rizvi S, Xiang X, Szabo A, Saeian K. Fatty Liver Disease: Survey of AASLD members. Gastroenterology 2009; (Suppl 1): A847.
     
16. Guichelaar M, Gawrieh S, Viker K, Krishnan A, Charlton M. RS738409GG Genotype of PNPLA3 in patients with medically complicated obesity-correlations with liver histology (NASH), insulin resistance and fibrinogen.  Hepatology 2010; 52 (Suppl):T255.
     
17. Gawrieh S, Martin L, Komorowski R, Wallace J, Goldblatt M, Santoro J, Makladi B, Viker K, Kissebah A, Charlton M, Olivier M.  A non-synonymous PNPLA3 gene variant is associated with nonalcoholic fatty liver disease severity in morbidly obese North Americans. Hepatology 2010;52 (Suppl):S637.
     
18. Gawrieh S, Ananthakrishnan A, Komorowski R, Wallace J, Goldblatt M, Makladi B, Kissebah A, Olivier M.  Smaller APOB and LDL particle sizes in NAFLD: A possible link to increased cardiovascular risk? Hepatology 2010; 52 (Suppl):S656.
     
19. Baillargeon P, Komorowski R, Wallace J, Ulitsky A, Goldblatt M, Gawrieh S. Liver Histopathology in Patients With Nonalcoholic Fatty Liver Disease and Obstructive Sleep Apnea. American Journal of Clinical Pathology 2010, 134:667.
     
20. Kwiatt J, Desai, P, Gawrieh, S, Saeian, K. Performance Feedback Impacts Quality Measures in the Management of Cirrhosis. Oral presentation DDW Chicago May 2011.